Peptides for Hair Loss: GHK-Cu, PTD-DBM, and Thymosin Beta-4

Written by Adam Maggio | Medically reviewed by Dr. Sarah Chen, PharmD, BCPS

GHK-Cu stimulates hair follicle growth and increases follicle size. PTD-DBM activates the Wnt/β-catenin pathway to promote hair growth. Thymosin Beta-4 promotes hair follicle stem cell activation. Topical application is the primary route for hair-related peptide therapy.

The Science of Hair Loss

Hair loss (alopecia) affects approximately 50% of men and 25% of women by age 50. The most common form, androgenetic alopecia (AGA), is driven by the action of dihydrotestosterone (DHT) on genetically susceptible hair follicles, causing them to miniaturize and eventually stop producing hair. Peptide-based interventions offer a novel approach to hair loss that targets the biology of hair follicle cycling rather than simply blocking DHT.

GHK-Cu: The Copper Peptide for Hair

GHK-Cu has demonstrated significant hair growth-promoting effects in both in vitro and clinical studies. It stimulates hair follicle growth, increases follicle size, prolongs the anagen (growth) phase of the hair cycle, and promotes the expression of vascular endothelial growth factor (VEGF), which improves blood supply to follicles. Clinical studies have shown GHK-Cu to be comparable to minoxidil in promoting hair growth, with a better tolerability profile. Topical application (1–5% solution or serum) is the primary route for hair applications.

PTD-DBM: Wnt Pathway Activation

PTD-DBM (Protein Transduction Domain-DBM) is a peptide that activates the Wnt/β-catenin signaling pathway — one of the most important regulators of hair follicle development and cycling. Wnt signaling drives hair follicle stem cell activation and the transition from the resting (telogen) to the growth (anagen) phase. A clinical study published in the Journal of Investigative Dermatology demonstrated that PTD-DBM significantly promoted hair growth in patients with androgenetic alopecia.

Thymosin Beta-4 for Hair Follicle Stem Cells

Thymosin Beta-4 (TB-500) promotes the activation of hair follicle stem cells and has been shown to promote hair growth in animal models. Its mechanism involves upregulation of actin polymerization and promotion of cell migration, which drives the activation of quiescent hair follicle stem cells. Topical application of TB-500 may complement GHK-Cu and PTD-DBM in a comprehensive hair growth protocol.

Combining Peptides with Conventional Treatments

Peptide-based hair treatments work best when combined with conventional approaches: finasteride (for DHT blockade in men), minoxidil (for vasodilation and follicle stimulation), and microneedling (which enhances topical peptide penetration and activates wound healing pathways that promote hair growth). This multi-modal approach addresses hair loss from multiple biological angles simultaneously.